266 results
Page 3 of 14
8-K
EX-99.1
00nfza
11 Jan 21
Exact Sciences Announces Preliminary Fourth Quarter 2020 Results
7:11am
424B7
dw7j29i5 nsrb
5 Jan 21
Prospectus with selling stockholder info
4:05pm
8-K
EX-99.1
mjqwb2e0dj9k
5 Jan 21
Exact Sciences Completes Acquisition of Thrive Earlier Detection, Creating a Leader in Blood-Based, Multi-Cancer Screening
8:31am
8-K
EX-99.1
so7 w314a80psh0
27 Oct 20
Exact Sciences Announces Entry into Agreements to Sell $870 million of Common Stock in Registered Direct Offering
7:13am
424B2
odxstwn
27 Oct 20
Prospectus for primary offering
7:12am
8-K
EX-2.1
j2s6v24
27 Oct 20
Exact Sciences to Acquire Thrive, Becoming a Leader In Blood-based, Multi-cancer Screening
7:04am
8-K
oxkw4p7oxxmeu7osbhsj
27 Oct 20
Exact Sciences to Acquire Thrive, Becoming a Leader In Blood-based, Multi-cancer Screening
7:04am
8-K
EX-99.1
9pnm8
27 Oct 20
Exact Sciences to Acquire Thrive, Becoming a Leader In Blood-based, Multi-cancer Screening
7:04am
8-K
EX-99
3h4li58r5
27 Oct 20
Exact Sciences Announces Third Quarter 2020 Results
7:03am
8-K
EX-10.1
dq9zhru3ffsz4r8
7 Oct 20
Entry into a Material Definitive Agreement
6:02am
8-K
EX-99
y2uvu40
30 Jul 20
Exact Sciences Announces Second Quarter 2020 Results
6:46pm
424B7
ibqbx5mfdnpdltx83oyg
2 Jun 20
Prospectus with selling stockholder info
12:00am
S-3ASR
gtizr2ndziq 3bc0
1 Jun 20
Automatic shelf registration
4:10pm
8-K
dvgk5pmi0kk1
21 Apr 20
Results of Operations and Financial Condition
4:32pm
8-K
EX-1.1
ql834
27 Feb 20
Exact Sciences Announces Offering of $850 Million Convertible Senior Notes Due 2028
5:09pm